[Clinical results of Fortum and Zinacef trial in Burn Centers of Russia].
Alekseev
A A
AA
Institute of Surgery of AV Vishnevskii, RAMN.
Krutikov
M G
MG
Smirnov
S V
SV
Malakhov
S F
SF
Filimonov
A A
AA
D000293:Adolescent; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D002053:Burn Units; D002056:Burns / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use*; D002444:Cefuroxime / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004333:Drug Administration Routes; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D012426:Russia; D014946:Wound Infection / Q000188:drug therapy* / Q000209:etiology
D002511:Cephalosporins; D002442:Ceftazidime; D002444:Cefuroxime